Semaglutide Testing: What Checks Happen Before and During Treatment

Does semaglutide show up on a drug test?

This is one of the most common questions people ask, usually because they're starting Wegovy and have an upcoming workplace health screen or medico-legal assessment. The short answer: standard drug panels (whether urine, saliva, or hair) do not test for semaglutide. Those panels are designed to detect controlled substances such as cannabis, opioids, benzodiazepines, cocaine, and amphetamines. Semaglutide belongs to none of those categories.

Semaglutide is a GLP-1 receptor agonist, a type of peptide hormone analogue. Detecting it requires a specific immunoassay or mass spectrometry method targeted at that compound, something only a specialist laboratory would run if it had a specific reason to. General occupational health panels do not include it.

If you have a specific concern about a particular test (for instance, a specialist sports or aviation medical) the clearest route is to ask the testing body directly what their panel covers. That check takes under a minute and gives you a definitive answer. You can also find more detail on whether semaglutide appears on drug tests in our dedicated explainer.

Being on a prescription medicine is not something you need to conceal in any case. Wegovy is a licensed treatment prescribed by a regulated clinician, and declaring it to a relevant medical examiner is both straightforward and appropriate.

What checks does a prescriber carry out before approving semaglutide?

Before a GPhC-registered Independent Prescriber approves semaglutide for weight management, they need enough information to judge whether the medicine is safe and appropriate for you specifically. This is not a formality, the assessment has real clinical content.

BMI is the starting point. The UK licence for Wegovy covers adults with a BMI of 30 or above, or 27 and above if a weight-related condition such as high blood pressure, raised cholesterol, type 2 diabetes, or obstructive sleep apnoea is present. Lower thresholds apply for some ethnic backgrounds under UK guidance.

Beyond BMI, the prescriber reviews your medical history for conditions that affect whether semaglutide is suitable, a personal or family history of medullary thyroid carcinoma, pancreatitis, or certain gastrointestinal conditions, for example. Current medicines matter too, both for interactions and because some conditions (such as type 2 diabetes managed with insulin or sulphonylureas) require additional care during dose changes. If you are also taking inositol, for instance, our page on whether you can take inositol with Wegovy covers what the evidence says about combining the two.

Routine blood tests are not universally required before starting treatment, but a prescriber may request recent results (particularly HbA1c, kidney function, or lipids) if your history suggests they're relevant. This varies by clinical circumstance, not by which pharmacy you use. The overview of semaglutide for weight management covers eligibility in more depth if you want to read around this before your consultation.

What monitoring typically continues once treatment is underway?

Semaglutide treatment is not a one-off prescription and done. Clinical guidelines expect ongoing review, and how nume approaches this reflects that expectation: every repeat order is clinically re-reviewed by a prescriber before it is dispensed, with no automatic renewals.

In practice, monitoring during treatment tends to focus on a few things. Weight progress is tracked to confirm the medicine is doing its job, NICE's guidance for semaglutide (Wegovy) notes that if less than 5% of body weight has been lost after six months on the maintenance dose, continuing should be reconsidered. Tolerability is reviewed too, because gastrointestinal side effects (nausea, loose stools, changes in appetite) are common early on and sometimes indicate that a dose increase should be slowed or paused.

If you have an underlying condition such as type 2 diabetes or hypertension, your prescriber or GP may want to monitor those more actively while your weight changes, since the medicine can affect blood sugar and blood pressure in ways that alter how other treatments need to be dosed. Our guide to semaglutide 1 mg dosing has detail on what that particular stage of the titration schedule involves and what to expect from it. The Wegovy treatment guide has more on what to expect across the course of treatment.

The NHS medicines page for semaglutide is a reliable plain-English reference for the monitoring considerations documented in the prescribing information.

What are home semaglutide test kits, and are they useful?

Search results for semaglutide testing occasionally surface products described as home test kits. These are laboratory-style immunoassay strips or sample-collection kits designed to detect the presence of semaglutide in urine or blood, typically used in clinical research, compliance monitoring, or forensic contexts, not in routine patient care.

They are not a way to assess whether semaglutide is working, whether you're eligible for treatment, or whether your dose is correct. A positive result simply means the compound is present in your system. It tells you nothing about efficacy, safety for your individual circumstances, or what happens next.

There is a separate page on what semaglutide test kits actually detect if you've come across one of these products and want to understand what it is measuring. For most people on Wegovy, the monitoring that matters is the regular clinical review built into a properly supervised prescribing pathway, not a home strip test.

If you have questions about what testing or monitoring would apply to your particular situation, the most direct route is to raise them during your consultation. Our clinical team, led by our clinical pharmacist prescriber, reviews each case individually, a real prescriber, looking at your specific history. For context on treatment costs alongside this clinical process, the weight-loss treatments page sets out what is included in a single transparent price, with no hidden charges.

If you're ready to find out whether semaglutide is clinically suitable for you, you can start your free consultation there. A prescriber will review your answers the same day.